|
LRRCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.522300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.844300E-04 |
| Normal-vs-Stage2 |
2.717600E-03 |
| Normal-vs-Stage3 |
6.376800E-03 |
| Normal-vs-Stage4 |
1.984440E-03 |
| Stage1-vs-Stage2 |
5.551000E-01 |
| Stage1-vs-Stage3 |
9.525000E-01 |
| Stage1-vs-Stage4 |
2.171800E-01 |
| Stage2-vs-Stage3 |
6.028800E-01 |
| Stage2-vs-Stage4 |
7.798400E-01 |
| Stage3-vs-Stage4 |
4.463200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.589600E-04 |
| Normal-vs-AfricanAmerican |
1.239640E-04 |
| Normal-vs-Asian |
3.808100E-04 |
| Caucasian-vs-AfricanAmerican |
2.000400E-01 |
| Caucasian-vs-Asian |
5.495600E-03 |
| AfricanAmerican-vs-Asian |
1.215590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.826330E-04 |
| Normal-vs-Female |
4.751600E-02 |
| Male-vs-Female |
5.535700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.103810E-03 |
| Normal-vs-Extreme_Weight |
2.001700E-03 |
| Normal-vs-Obese |
4.132000E-02 |
| Normal-vs-Extreme_Obese |
1.857700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.689600E-01 |
| Normal_Weight-vs-Obese |
1.606820E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.802200E-01 |
| Extreme_Weight-vs-Obese |
2.410800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.278600E-01 |
| Obese-vs-Extreme_Obese |
4.260800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.342300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.416400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.564400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.702400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.812200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.276200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.478600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.725900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.126400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.403200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.560300E-03 |
| Normal-VS-Type2 PRCC |
1.67969000000046E-05 |
| Normal-VS-KIRP CIMP |
2.219800E-01 |
| Normal-VS-Unclassified PRCC |
2.454100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.102200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.219800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.694000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.413560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.069790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.145600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71230000001188E-06 |
| Normal-vs-N1 |
4.143800E-03 |
| Normal-vs-N2 |
7.188200E-01 |
| N0-vs-N1 |
2.013400E-01 |
| N0-vs-N2 |
7.224200E-02 |
| N1-vs-N2 |
2.511400E-01 |
|
|
